DOI QR코드

DOI QR Code

Melanoma Incidence Mortality Rates and Clinico-Pathological Types in the Siberian Area of the Russian Federation

  • Published : 2014.03.01

Abstract

Russian rates for melanoma incidence and mortality are relatively low as compared to some other white populations but the tumor is of increasing importance. In this paper, data are based on a retrospective descriptive analysis of melanoma epidemiology and clinicopathological characteristics in Krasnoyarsk Territory belonging to the Siberian Federal District of the Russian Federation. The age-adjusted incidence and mortality rates for the period 1996-2009 were determined with subsequent retrospective analysis of clinicopathological data of 103 primary melanoma cases. Our results showed that incidence and mortality rates in the region under consideration match the Russian national trends and correspond to epidemiological data of the countries of Eastern Europe. Stratification of melanoma cases by age, sex, clinicopathological state and localization revealed a prevalence of lesions on the trunk and lower extremities. Most melanomas diagnosed were of superficial spreading type and the third Clark's level of tumor invasion and stage II according to AJCC. In spite of comparatively low rates of incidence and mortality the trend to increase of melanoma cases in the region under consideration obviously calls for more attention and further investigation.

References

  1. Tsai T, Vu C, Henson DE (2005) Cutaneous, ocular and visceral melanoma in African Americans and Caucasians. Melanoma Res, 15, 213-7. https://doi.org/10.1097/00008390-200506000-00012
  2. Richards TB, Johnson CJ, Tatalovich Z, et al (2011). Association between cutaneous melanoma incidence rates among white US residents and country-level estimates of solar ultraviolet exposure. J Am Acad Dermatol, 2011, 50-7.
  3. Schubert A (2012) Malignant melanoma of the skin: does screening for cancer influence the incidence and mortality? Gesundheitswesen, 74, 154-9. https://doi.org/10.1055/s-0030-1270509
  4. Singh SD, Ajani UA, Johnson CJ, et al (2011). Association of cutaneous melanoma incidence with area-based socioeconomic indicators-United States, 2004-2006. J Am Acad Dermatol, 65, 58-8. https://doi.org/10.1016/j.jaad.2011.02.023
  5. Van der Aa MA, de Vries E, Hoekstra HJ, et al (2011). Sociodemographic factors and incidence of melanoma in the Netherlands. Eur J Cancer, 47, 1056-0. https://doi.org/10.1016/j.ejca.2010.11.020
  6. Weir HK, Marrett LD, Cokkinides V, et al (2011). Melanoma in adolescents and young adults (ages 15-39 years): United States, 1999-2006. J Am Acad Dermatol, 65, 38-9.
  7. Youl PH, Youlden DR, Baade PD (2012). Changes in the site distribution of common melanoma syb-types in Queensland, Australia over time: implications for public health campaigns. Br J Dermatol, 168, 136-4.
  8. Joosse A, Vries de E, Eckel R, et al (2011). Gender differences in melanoma survival: female patients have a decreased risk of metastasis. J Invest Dermatol, 131, 719-26. https://doi.org/10.1038/jid.2010.354
  9. Forsea AM, Marmol Del V, Vries de E, et al (2012). Melanoma incidence and mortality in Europe: new estimates, persistent disparities. Br J Dermatol, 167, 1124-30. https://doi.org/10.1111/j.1365-2133.2012.11125.x
  10. Fuglede NB, Brinck-Claussen UO, Deltour I, et al (2011). Incidence of cutaneous malignant melanoma in Denmark, 1978-2007. Br J Dermatol, 165, 349-53. https://doi.org/10.1111/j.1365-2133.2011.10361.x
  11. Jemal A, Saraiya M, Patel P, et al (2011). Recent trends in cutaneous melanoma incidence and death rates in the United States. J Am Acad Dermatol, 65, 17-5. https://doi.org/10.1016/j.jaad.2010.12.010
  12. MacKie RM, Bray C, Vestey J (2003) Melanoma incidence and mortality in Scotland 1979-2003. Br J Cancer, 96, 1772-7.
  13. Micu E, Baturaite Z, Juzeniene A, et al (2012). Superficialspreading and nodular melanomas in Norway: a comparison by body site distribution and latitude gradients. Melanoma Res, 22, 460-5. https://doi.org/10.1097/CMR.0b013e3283599cc3
  14. Mocellin S, Nitti D (2001). Cutaneous melanoma in situ: translation evidence from a large population-based study. Oncologist, 16, 896-3.
  15. Pleasance ED, Cheetham RK, Stephens PJ (2010) A comprehensive catalogue of somatic mutations from a human cancer genome. Nature, 463, 191-6. https://doi.org/10.1038/nature08658
  16. Pruthi DK, Guilfoyle R, Nugent Z, et al (2009). Incidence and anatomic presentation of cutaneous malignant melanoma in central Canada during a 50-year period: 1956 to 2005. J Am Acad Dermatol, 61, 44-0. https://doi.org/10.1016/j.jaad.2009.01.020
  17. Rao UNM, Lee SJ, Luo W, et al (2010). Presence of tumorinfiltrating lymphocytes and a dominant nodule within primary melanoma are prognostic factors for relapse-free survival of patients with thick (T4) primary melanoma: pathologic analysis of the E1690 and E1694 intergroup trials. Am J Clin Pathol, 133, 646-53. https://doi.org/10.1309/AJCPTXMEFOVYWDA6
  18. Busam KJ, Antonescu CR, Marghoob AA, et al (2001). Histologic classification of tumor-infiltrating lymphocytes in primary cutaneous malignant melanoma: a study of interobserver agreement. Am J Clin Pathol, 115, 856-60. https://doi.org/10.1309/G6EK-Y6EH-0LGY-6D6P
  19. Azarjana K, Ozola A, Ruklisa D, et al (2012). Melanoma epidemiology, prognosis and trends in Latvia. J Eur Acad Dermatol Venereol, 27, 1352-9.
  20. Balch CM, Gershenwald JE, Soong SJ, et al (2011). Update on the melanoma staging system: the importance of sentinel node staging and primary tumor mitotic rate. J Surg Oncol, 104, 379-5. https://doi.org/10.1002/jso.21876
  21. Bradford PT, Anderson WF, Purdue Mp, et al (2010). Rising melanoma incidence rates of the trunk among young women in the United States. Cancer Epidemiol Biomarkers Prev, 19, 2401-6. https://doi.org/10.1158/1055-9965.EPI-10-0503
  22. Chissov VI, Starinsky VV, Petrova GV (2011). Cancer in Russia in 2010 (incidence and mortality). Moscow: Herzen Moscow Research Oncology Institute, pp 15-7.
  23. Clark WH, Elder DE, Guerry D, et al (1981). A model for predicting survival in stage 1 melanoma based upon tumor progression. J Natl Cancer Inst, 81, 1893-4.
  24. Curado MP, Edwards B, Shin HR, et al (2007). Cancer incidence in five continents (Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, eds), Lyon: IARC scientific publications, pp 280-8.
  25. Deichmann M, Krahl D, Thome M, et al (2006). The oncogenic B-raf V599E mutation occurs more frequently in melanomas at sun-protected body sites. Int J Oncol, 29, 139-5.
  26. Elwood JM, Gallagher RP (1998) Body site distribution of cutaneous malignant melanoma in relationship to patterns of sun exposure. Int J Cancer, 78, 276-80. https://doi.org/10.1002/(SICI)1097-0215(19981029)78:3<276::AID-IJC2>3.0.CO;2-S
  27. Erdman F, Lortet-Tieulent J, Schuz J, et al (2013). International trends in the incidence of malignant melanoma 1953-2008- are recent generations at higher or lower risk? Int J Cancer, 132, 385-90. https://doi.org/10.1002/ijc.27616

Cited by

  1. Assessing a Sun Protection Program Aimed at Greek Elementary School Students for Malign Melanoma Prevention vol.15, pp.12, 2014, https://doi.org/10.7314/APJCP.2014.15.12.5009
  2. A Retrospective Multicenter Evaluation of Cutaneous Melanomas in Turkey vol.15, pp.23, 2015, https://doi.org/10.7314/APJCP.2014.15.23.10451
  3. MicroRNA-328 Inhibits Proliferation of Human Melanoma Cells by Targeting TGFB2 vol.16, pp.4, 2015, https://doi.org/10.7314/APJCP.2015.16.4.1575
  4. Genetic analysis of melanocortin 1 receptor red hair color variants in a Russian population of Eastern Siberia vol.27, pp.2, 2018, https://doi.org/10.1097/CEJ.0000000000000317